Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure

Karly C. Sourris
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Departments of Medicine, Immunology and Physiology, Monash University, Australia
/ Jasmine G. Lyons
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
/ Sonia L. Dougherty
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
/ Vibhasha Chand
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Departments of Medicine, Immunology and Physiology, Monash University, Australia
/ Nora E. Straznicky
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
/ Markus P. Schlaich
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
/ Mariee T. Grima
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
/ Mark E. Cooper
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Departments of Medicine, Immunology and Physiology, Monash University, Australia
/ Bronwyn A. Kingwell
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Departments of Medicine, Immunology and Physiology, Monash University, Australia
/ Maximilian P.J. de Courten
  • Copenhagen School of Global Health, Copenhagen University, Denmark
/ Josephine M. Forbes
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Departments of Medicine, Immunology and Physiology, Monash University, Australia
  • Glycation and Diabetes, Mater Medical Research Institute, South Brisbane, Australia
/ Barbora de Courten
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  • Department of Biomedical Sciences, Copenhagen University, Denmark
  • :
Published Online: 2013-03-23 | DOI: https://doi.org/10.1515/cclm-2012-0850

Abstract

Background: High levels of circulating advanced glycation end products (AGEs) can initiate chronic low-grade activation of the immune system (CLAIS) with each of these factors independently associated with cardiovascular (CV) morbidity and mortality. Therefore, our objective was to characterize the relationship between serum AGEs, CLAIS and other risk factors for CV disease in normotensive non-diabetic individuals.

Methods: We measured body mass index (BMI), waist-to-hip ratio (WHR), blood pressure, lipid and glucose profile in 44 non-diabetic volunteers (17 female, 27 males). Carboxymethyl-lysine (CML) was measured by ELISA as a marker for circulating AGEs and NF-κB p65 activity as an inflammatory marker by DNA-binding in peripheral blood mononuclear cells lysates (PBMC).

Results: Plasma CML concentrations were related to diastolic blood pressure (r=−0.51, p<0.01) independently of age, sex, BMI and WHR (p<0.05). Diastolic blood pressure was also related to NF-κB activity in PBMC (r=0.47, p<0.01) before and after adjustment for age, sex, BMI and WHR (p<0.05). Plasma CML concentrations were related to the pulse pressure before (r=0.42; p<0.05) and after adjustment for age, sex, BMI and waist (p<0.05). Neither CML nor NF-κB activity were related to systolic blood pressure (both p=ns). Plasma CML concentrations were not associated with plasma lipid or glucose concentrations (all p=ns).

Conclusions: Plasma AGE levels and NF-κB activity in PBMC were independent determinants of diastolic and pulse pressure in healthy normotensive individuals. This association suggests a role for AGEs in the etiology of hypertension, possibly via the initiation of CLAIS and aortic stiffening.

Keywords: advanced glycation end products; alkaline phosphatase; blood pressure; central obesity; chronic low-grade inflammation; NF-κB activity

Corresponding author: A/Prof. Barbora de Courten, MD, PhD, MPH, FRACP, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, 3004, VIC, Australia, Phone: +61 3 85321353, Fax: +61 3 85321111, E-mail:


Received: 2012-12-05

Accepted: 2013-02-14

Published Online: 2013-03-23

Published in Print: 2014-01-01


Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 52, Issue 1, Pages 129–138, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2012-0850, March 2013

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Jeremy N. Adams, Susan E. Martelle, Laura M. Raffield, Barry I. Freedman, Carl D. Langefeld, Fang-Chi Hsu, Joseph A. Maldjian, Jeff D. Williamson, Christina E. Hugenschmidt, J. Jeffery Carr, Amanda J. Cox, and Donald W. Bowden
Journal of Diabetes and its Complications, 2015
[2]
Akira Suehiro, Kagehiro Uchida, Mamoru Nakanishi, and Ichiro Wakabayashi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2015
[3]
Barbora de Courten, Aya Mousa, Negar Naderpoor, Helena Teede, Maximilian P J de Courten, and Robert Scragg
Trials, 2015, Volume 16, Number 1

Comments (0)

Please log in or register to comment.